U.S. Markets closed

Weekly CEO Buys Highlight

- By Joy Hu

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

Allogene Therapeutics CEO bought 40,000 shares

Allogene Therapeutics Inc. (ALLO) President and CEO David D. Chang bought 40,000 shares on Oct. 15 at a price of $18.00. The price of the stock has increased by 30% since.


Allogene Therapeutics is a clinical stage biotechnology company developing allogeneic CAR T (AlloCAR T(TM)) therapies for cancer. The company has a market cap of $2.77 billion. Its shares traded at $23.40 as of Oct. 19.

On Sept. 14, the company announced it had filed an S-1 registration statement with the Securities and Exchange Commission relating to a proposed offering of its common stock.

Director Owen N. Witte bought 15,000 shares on Oct. 15 at a price of $18. The price of the stock has increased by 30% since.

Director Franz B. Humer bought 30,000 shares on Oct. 15 at a price of $18. The price of the stock has increased by 30% since.

Director and 10% Owner Arie Belldegrun bought 35,000 shares on Oct. 15 at a price of $18. The price of the stock has increased by 30% since.

10% Owner Pfizer Inc. bought 55,556 shares on Oct. 15 at a price of $18. The price of the stock has increased by 30% since.

10% Owner TPG Group Holdings SBS Advisors bought 675,000 shares on Oct. 15 at a price of $18. The price of the stock has increased by 30% since.

Conagra Brands CEO bought 14,184 shares

Conagra Brands Inc. (CAG) President and CEO Sean Connolly bought 14,184 shares on Oct. 12 at a price of $35.25. The price of the stock has increased by 1.67% since.

Conagra Brands produces and sells packaged food in a variety of categories and in various retail channels across frozen, refrigerated and shelf-stable temperature classes in North America. The company has a market cap of $14.63 billion. Its shares traded at $35.84 with a price-earnings ratio of 17.21 as of Oct. 19.

Net income for the first quarter of 2018 was $178.2 million, compared to $153.3 million for the prior-year quarter.

Executive Vice President and Chief Financial Officer David S. Marberger bought 2,836 shares on Oct. 12 at a price of $35.25. The price of the stock has increased by 1.67% since.

Director Thomas K. Brown bought 7,092 shares on Oct. 12 at a price of $35.25. The price of the stock has increased by 1.67% since.

Texas Capital Bancshares CEO bought 3,000 shares

Texas Capital Bancshares Inc. (TCBI) President and CEO C. Keith Cargill bought 3,000 shares on Oct. 19 at a price of $67.59. The price of the stock has decreased by 1.12% since.

Texas Capital Bancshares is engaged in providing lending services to businesses. Its services included credit solutions, treasury and liquidity services, mortgage finance, private wealth solution and personal banking solution. The company has a market cap of $3.35 billion. Its shares traded at $66.83 with a price-earnings ratio of 12.73 as of Oct. 19.

Net income for the third quarter of 2018 was $85.55 million compared to $58.68 million for the prior-year period.

Texas President CLO-TCB Vince A. Ackerson bought 2,000 shares on Oct. 19 at a price of $67. The price of the stock has decreased by 0.25% since.

Fastenal CEO bought 2,000 shares

Fastenal Co. (FAST) CEO and President Daniel L. Florness bought 2,000 shares on Oct. 12 at a price of $51.95. The price of the stock has increased by 0.1% since.

Fastenal is an industrial supplies company. It distributes maintains, repairs, and operates supplies to industrial and construction customers. Its product portfolio includes OEM fasteners, safety products, tools and equipment. The company has a market cap of $14.93 billion. Its shares traded at $52 with a price-earnings ratio of 20.31 as of Oct. 19.

Net earnings for the third quarter of 2018 were $197.6 million compared to $143.1 million for the prior-year period.

Chief Financial Officer and Executive Vice President Holden Lewis bought 500 shares on Oct. 16 at price of $52.28. The price of the stock has decreased by 0.54% since.

Senior Executive Vice President Terry Modock Owen bought 1,500 shares on Oct. 12 at a price of $52.07. The price of the stock has decreased by 0.13% since.

CymaBay Therapeutics CEO bought 5,000 shares

CymaBay Therapeutics Inc. (CBAY) CEO Sujal Shah bought 5,000 shares on Oct. 15 at a price of $9.90. The price of the stock has increased by 5.25% since.

CymaBay Therapeutics is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases. The company has a market cap of $615.33 million. Its shares traded at $10.42 as of Oct. 19.

Net loss for the second quarter of 2018 was $17.5 million compared to $8.9 million for the prior-year period.

For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.

Read more here:

52-Week Company Lows

Weekly CEO Buys Highlight

52-Week Company Lows

This article first appeared on GuruFocus.